In addition, the ligand-dependent activation of RET can be important for treating various disease conditions caused by neuronal degeneration or the disturbances of functional activity of neurons, e.g., Parkinson’s disease (PD), neuropathic pain, retinitis pigmentosa (RP), and obesity (Figure 2). The gene discussed is RET; the disease is obesity due to melanocortin 4 receptor deficiency.